Michael Samar is a Chief Financial Officer with extensive experience in finance and business operations within the life sciences sector. They served as Director of Financial Planning and Analysis at Onyx Pharmaceuticals and have held senior roles at organizations such as Assembly Biosciences, Inc. and Acorda Therapeutics, Inc. Currently, Michael is the Chief Financial Officer at Noema Pharma and serves on the Board of Directors and as Treasurer for OUTbio. They hold a BSBA in Business Administration with a focus in Finance from Bryant University and an MBA from Villanova University.
This person is not in any teams
This person is not in any offices